Author:
Wu Xiaojing,Kong Qian,Zhan Liying,Qiu Zhen,Huang Qin,Song Xuemin
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1334–49.
2. Li C, Yang D, Cao X, Wang F, Jiang H, Guo H, Du L, Guo Q, Yin X. LFG-500, a newly synthesized flavonoid, attenuates lipopolysaccharide-induced acute lung injury and inflammation in mice. Biochem Pharmacol. 2016;113:57–69.
3. Zhao Z, Tang X, Zhao X, Zhang M, Zhang W, Hou S, et al. Tylvalosin exhibits anti-inflammatory property and attenuates acute lung injury in different models possibly through suppression of NF-kappaB activation. Biochem Pharmacol. 2014;90(1):73–87.
4. Georgene S, George G, Tony TC, Nagamani S. Incidence and outcome of acute lung injury and acute respiratory distress syndrome in the surgical intensive care unit. Indian J Crit Care Med. 2014;18(10):659–65.
5. Zgraggen BR, Tornic J, Müller-Edenborn B, Reyes L, Booy C, Beck-Schimmer B. Acute lung injury: apoptosis in effector and target cells of the upper and lower airway compartment. Clin Exp Immunol. 2010;161(2):324–31.